Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q2 2020 · 10-Q
Revenue$27.00K$27.00K−68.6% vs Q2 2019 Net Income-$3.57M-$3.57MN/M vs Q2 2019 EPS Diluted-$0.46-$0.46N/M vs Q2 2019 Operating Income-$3,574,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$2,347,000N/M Margins · derivedOperating margin-13237.0%−8862.6 pt vs Q2 2019
Net margin-13233.3%−8872.9 pt vs Q2 2019
ended Jun 30, 2020 · filed Aug 13, 2020 · 44 d after period end